CareersInvestor RelationsPress RoomCOVID-19
Login

Welcome to Siemens Healthineers in the USA

Tools & Resources

News from Siemens Healthineers USA

Three dimensional healthcare: A frictionless care experience

 09/13/2022

Explore how systemic adjustments make it possible to create a customized and respectful centered care experience.

Improving patient experience

Future of cancer care: Moving from promise to reality

 09/07/2022

Near-term solutions are beginning to have a positive impact of a future with more comprehensive, multimodal, integrated cancer care.

High-value cancer-care

The future of precision cancer care

 08/31/2022

Cancer treatment is full of challenges. This paper looks into the future of how precision cancer care can help patients & healthcare providers alike.

Expanding precision medicine

Built to care: cancer centers for the future

 08/22/2022

Integrated multi-disciplinary oncology centers are becoming an increasingly popular care delivery model for providers. Identify the factors that healthcare providers should consider when deciding to build new integrated cancer centers – from planning via construction to operation.

Transforming care delivery
Healthcare: available, affordable, and accepted – Best practices from three continents
 08/04/2022
Half the world’s population does not have access to healthcare. The barriers that stand between people and the care they need can be characterized as availability, affordability, and acceptability. Explore three best practices from three continents on how to overcome those challenges.
Transforming care delivery

Contact Us

Siemens Medical Solutions USA, Inc.

40 Liberty Boulevard
Malvern, PA 19355
United States of America

1
The Dosimetry Research Tool shown in the image is an Investigational Device. Limited by Federal (or United States) law to investigational use. This device is exclusively for clinical investigations. This Investigational Device does not fulfill all the essential requirements according to the European Medical Device Directive (93/42/EEC) and its national implementations. It is not commercially available in the European Union, or other countries worldwide.